When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SRDX - FDA clears Surmodics Pounce Thrombus Retrieval System
Surmodics Inc.
Surmodics (SRDX) has received FDA 510(k) clearance for its Pounce Thrombus Retrieval System for the treatment of peripheral artery disease ((PAD)). The Pounce Thrombus is intended for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature. PAD is a serious and underdiagnosed circulatory condition caused by build-up of arterial plaque, most commonly in the legs.